Mikael Elias shares his vision for bridging the gap between scientific discovery and market application.

Unique collaboration yields a much-needed common language for genetic biocontrol technology development.

Graduate student Christopher Belica is developing tools to inhibit APOBEC3B, an enzyme linked to cancer adaptation and treatment resistance.

Nisha Vishwanathan believes that if you can understand Game of Thrones, you can understand methylated peptides.